Wilmington, Delaware, Sept. 24, 2024 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Custom Antibody Services Market by Service (Antibody Development, Antibody Production and Purification and Antibody Fragmentation and Labeling), by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Others), Source (Mice, Rabbit and Others), Application (Oncology, Infectious Diseases, Neurology, Immunology, Cardiovascular Diseases and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the custom antibody services market was valued at $0.6 billion in 2023, and is estimated to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033. 

Prime determinants of growth   

Increase in prevalence of chronic diseases, rise in funding from government and private sectors, and surge in R&D activities are the major factors that drive the growth of the custom antibody services market. However, the high cost of customization may restrict market growth. Moreover, rise in technological advancements and high growth potential in developing economies offer remunerative opportunities for the expansion of the global custom antibody services market.   

Request Sample of the Report on Custom Antibody Services Market Forecast 2033 –https://www.alliedmarketresearch.com/request-sample/A324397 

Report coverage & details

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A324397 

Segment Highlights  

Rise in adoption of antibody development services  

By service, the antibody development segment plays a pivotal role in the market. This is attributed to increasing R&D investments, particularly in biopharmaceuticals and personalized medicine, where precise antibody specificity is essential. Technological advancements, such as recombinant DNA technology and hybridoma techniques, enhance the efficiency and customization of antibody development, further bolstering its significance in the market.  

Rise in adoption of monoclonal antibodies  

By type, the monoclonal antibodies segment plays a pivotal role in the market. This is attributed to their specificity and consistency in targeting particular antigens. Their extensive use in research, diagnostics, and therapeutic applications drives demand, as they offer high precision and reproducibility. Advances in monoclonal antibody technology also contribute to their prominent position.  

Rise in demand for rabbits in custom antibody services  

By source, the rabbit segment plays a pivotal role in the market. This is attributed to its ability to produce high-affinity antibodies and a wide range of immune responses. In addition, rabbits are also preferred for their versatility in producing antibodies against challenging antigens along with the increasing demand for detailed and accurate immunoassays, drives the segment growth.  

Rise in adoption of services in infectious disease  

By application, the infectious disease segment plays a pivotal role in the market. This is attributed to high demand for specialized antibodies for detecting and studying pathogens. Custom antibodies are crucial for developing diagnostic assays and therapeutic interventions against infectious agents. In addition, the ongoing need for accurate and rapid diagnostics in managing infectious diseases drives significant investment in custom antibody services.  

The pharmaceutical & biotechnology companies’ segment to dominate during the forecast period  

By end user, the pharmaceutical & biotechnology companies’ segment has a significant share in the market. This is attributed to high demand for specialized antibodies used in drug discovery, development, and therapeutic applications. These companies rely on custom antibody services to produce antibodies tailored for specific targets, enhancing their research and development efforts. In addition, the ongoing advancements in biotechnology and increased outsourcing of antibody production to specialized service providers further supports the segment growth.  

For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A324397 

Regional Outlook  

North America to Dominate by 2033  

North America has a significant share in the custom antibody services market and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the advanced research infrastructure and substantial R&D investment in the region. The presence of leading pharmaceutical and biotechnology companies also drives demand for custom antibody services. In addition, government support and funding for biomedical research, coupled with technological advancements in antibody production, further boost the market. Furthermore, the rise in prevalence of chronic diseases necessitates targeted therapies, increasing the need for custom antibodies thereby driving the segment growth.  

Players  

• Thermo Fisher Scientific Inc.  

• Agilent Technologies, Inc.  

• Sino Biological, Inc.  

• Bio-Rad Laboratories, Inc.  

• Kaneka Eurogentec S.A.  

• YenZym Antibodies, LLC.  

• OriGene Technologies, Inc.   

• Laboratory Corporation of America Holdings  

The report provides a detailed analysis of these key players in the global custom antibody services market. These players have adopted different strategies such as agreement, acquisition, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.   

Get Customized Reports with your Requirements – https://www.alliedmarketresearch.com/request-for-customization/A324397 

Recent Development in Custom Antibody Services Industry  

• In March 2024, Sino Biological, Inc., a biotechnology company, announced the formation of a services partnership with Toronto, Canada-based Rapid Novor, Inc. Under the terms of this agreement, Sino Biological will market Rapid Novor’s proprietary de novo REmAb monoclonal antibody (mAb) sequencing service in combination with its custom mAb development and production services.  

Trending Reports in Healthcare Industry:  

South Korea ECG Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

Direct Fed Microbial Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

Airway Management Devices Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

Women’s Health App Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter